Soluble antibody complexes for T cell or NK cell activation and expansion
US12351825B2 · kind B2 · utility
0Cited by
6References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 4, 2021 |
| Grant date | Jul 8, 2025 |
| Priority date | — |
| Expiry date | May 9, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/998
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This disclosure provides compositions and methods for the activation and expansion of human T cells or NK cells using soluble monospecific antibody complexes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.